title: Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant.
authors: Department of Medicine - Feist-Weiller Cancer Center, LSU Health Sciences Center - Shreveport , Shreveport, LA , USA.
authors: Srinivas S
authors: SS
authors: Devarakonda
authors: Jaime L
authors: JL
authors: Shahan
authors: Amol
authors: A
authors: Takalkar
authors: Shubnum I
authors: SI
authors: Chaudhery
authors: Gary
authors: G
authors: Jean
authors: Nebu V
authors: NV
authors: Koshy
authors: Gerhard C
authors: GC
authors: Hildebrandt
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D020350:Graft vs Tumor Effect / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy* / Q000276:immunology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000628:therapy; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D000077337:Vorinostat
chemical_list: D000970:Antineoplastic Agents; D006877:Hydroxamic Acids; D000077337:Vorinostat